Open Access 01.12.2021 | Correction
Correction to: Baseline plasma KL-6 level predicts adverse outcomes in patients with idiopathic pulmonary fibrosis receiving nintedanib: a retrospective real-world cohort study
Erschienen in: BMC Pulmonary Medicine | Ausgabe 1/2021